Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Thursday 09:00 PDT / 12:00 EDT / 16:00 GMT / 17:00 CET

Sponsor

Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Cell and gene therapy requires manufacturing platforms that support the growth of both suspension and adherent cell types while meeting stringent quality and scalability standards.

In this webinar, two experts will explore advanced manufacturing strategies and GMP-compliant solutions for expanding mesenchymal stromal cells (MSCs), induced pluripotent stem cells (iPSCs), T cells, and CAR-T cells.

The webinar will address key topics, including:

Methods for expanding CAR-T cells from very low quantities of starting material to therapeutic doses
Tailoring expansion parameters to enhance Tscm frequency for better outcomes
Leveraging automated sensing technologies to maintain optimal growth conditions for consistent, high-quality results.

Join us to discover how innovative manufacturing approaches can drive efficiency, scalability, and the production of high-quality cell therapy products.

In this webinar you will learn more about:

Delivering a consistent and customized cell expansion environment utilizing hollow-fiber perfusion technology
Enhancing GMP compliance and process standardization
Scaling up and out to manufacture high-quality suspension and adherent cells efficiently

Mindy Miller

Head of Cell Therapy Scientific Development at Terumo Blood and Cell Technologies

Mindy Miller currently serves as the Sr. Manager of Cell Therapy Scientific Affairs at Terumo BCT. She holds a doctorate in Immunology from the University of Missouri and conducted post-doctoral studies at the University of Missouri and National Jewish Health in Denver, CO. Mindy’s expertise has focused on the development of immune cells in the context of autoimmunity, allergy, and cancer. She has authored over 30 scientific publications, obtained independent funding, and is the recipient of the Young Investigator Award from the American Association of Immunologists.

Nathan Frank

Senior Research Scientist at Terumo Blood and Cell Technologies

Nate has more than a decade of experience optimizing parameters for cell and gene therapy production and scale-up. He has specialized expertise in hollow-fiber bioreactor process development for a range of cell types aimed at various applications in regenerative medicine and immunotherapy. He is a two-time National Science Foundation fellow and has a passion for teaching and communicating science to a wide range of audiences from established professionals to middle and high school students who are just beginning their scientific journey.